| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Dr. Raymond Alexanian: Pioneering Contributions to Multiple Myeloma Research, Treatment, and the Concept of Curability
|
Fotiou, Despina
|
|
|
25 |
3 |
p. 156-161
|
artikel
|
| 2 |
Editorial Board
|
|
|
|
25 |
3 |
p. A1-A2
|
artikel
|
| 3 |
Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France
|
Ysebaert, Loïc
|
|
|
25 |
3 |
p. e173-e181
|
artikel
|
| 4 |
First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline Consortium
|
Khan, Sahar
|
|
|
25 |
3 |
p. e151-e172
|
artikel
|
| 5 |
Incidence, Risk Factors and Early Prediction of Doxorubicin-Induced Cardiotoxicity by Global Longitudinal Strain and Cardiac Biomarkers in Indian Patients With Lymphoma: A Prospective Observational Study
|
kumar, Lucky
|
|
|
25 |
3 |
p. e143-e150
|
artikel
|
| 6 |
Lenalidomide in Transfusion-Dependent IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes and Isolated Del(5q): Results of a European Postauthorization Safety Surveillance Study
|
Poloni, Antonella
|
|
|
25 |
3 |
p. e131-e142
|
artikel
|
| 7 |
Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor–Naive or –Experienced Myelofibrosis Treated With Momelotinib
|
Harrison, Claire N.
|
|
|
25 |
3 |
p. 199-211
|
artikel
|
| 8 |
Measurable Residual Disease Testing Following Nonintensive Chemoimmunotherapy is Predictive of Need for Maintenance Therapy in Previously Untreated Mantle Cell Lymphoma: A Wisconsin Oncology Network Study
|
Chang, Julie E.
|
|
|
25 |
3 |
p. 188-198
|
artikel
|
| 9 |
Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy
|
Askeland, Frida Bugge
|
|
|
25 |
3 |
p. e127-e130
|
artikel
|
| 10 |
Predictors of Local Control With Palliative Radiotherapy for Multiple Myeloma
|
Gao, Robert W.
|
|
|
25 |
3 |
p. 212-218
|
artikel
|
| 11 |
Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Asciminib in Clinical Practice in the United States
|
Atallah, Ehab L.
|
|
|
25 |
3 |
p. 178-187.e2
|
artikel
|
| 12 |
SOHO State of the Art Updates and Next Questions | Contemporary Standard of Care Therapy for Richter's Transformation and Future Directions
|
Jensen, Christopher E.
|
|
|
25 |
3 |
p. 135-141
|
artikel
|
| 13 |
SOHO State of the Art Updates and Next Questions | Measuring Patient-Reported Outcomes (PROs) and Treatment Tolerability in Patients With Hematologic Malignancies
|
Major, Ajay
|
|
|
25 |
3 |
p. 142-155
|
artikel
|
| 14 |
Table of Contents
|
|
|
|
25 |
3 |
p. A5-A7
|
artikel
|
| 15 |
The Impact of Social Determinants of Health on Peripheral T Cell Lymphoma Outcomes: Treatment Center-Type Emerges as a Powerful Prognostic Indicator
|
Mead, Monica
|
|
|
25 |
3 |
p. 162-177
|
artikel
|
Tijdschrift beschrijving